Loading…
Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential
The osteogenic Runt-related (Runx2) transcription factor negatively regulates proliferation and ribosomal gene expression in normal diploid osteoblasts, but is up-regulated in metastatic breast and prostate cancer cells. Thus, Runx2 may function as a tumor suppressor or an oncogene depending on the...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 2007-12, Vol.104 (50), p.19861-19866 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The osteogenic Runt-related (Runx2) transcription factor negatively regulates proliferation and ribosomal gene expression in normal diploid osteoblasts, but is up-regulated in metastatic breast and prostate cancer cells. Thus, Runx2 may function as a tumor suppressor or an oncogene depending on the cellular context. Here we show that Runx2-deficient primary osteoblasts fail to undergo senescence as indicated by the absence of β-gal activity and p16INK⁴a tumor suppressor expression. Primary Runx2-null osteoblasts have a growth advantage and exhibit loss of p21WAF¹/CIP¹ and p19ARF expression. Reintroduction of WT Runx2, but not a subnuclear targeting-defective mutant, induces both p21WAF/CIP¹ and p19ARF mRNA and protein resulting in cell-cycle inhibition. Accumulation of spontaneous phospho-H2A.X foci, loss of telomere integrity and the Mre11/Rad50/Nbs1 DNA repair complex, and a delayed DNA repair response all indicate that Runx2 deficiency leads to genomic instability. We propose that Runx2 functions as a tumor suppressor in primary diploid osteoblasts and that subnuclear targeting contributes to Runx2-mediated tumor suppression. |
---|---|
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0709650104 |